Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06653426
NA

The NaBu Effect on Menstruation in Women

Sponsor: Magdy Milad, MD

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.

Official title: The Effect of Sodium Butyrate on Menstrual Symptoms in Women

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2024-10-01

Completion Date

2025-10

Last Updated

2024-12-13

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Sodium Butyrate (NaBu)

Participants will self-administer Sodium Butyrate (NaBu) daily for 12 weeks. The study aims to evaluate the effect of NaBu on menstrual symptoms by comparing symptom severity before and during the intervention. Participants will maintain an electronic diary (eDiary) to record their daily symptom severity, which will be used to assess changes over time. Regular follow-ups will be conducted to monitor progress and address any side effects or concerns.

Locations (1)

Northwestern University - Northwestern Medicine, Lavin Family Pavilion

Chicago, Illinois, United States